Introduction
Pioneering Stem Cell and Immune Cell Research
The company is a leading research-driven organization specializing in stem cell and immune cell research. It excels at turning scientific breakthroughs into practical solutions, and is also a dedicated producer of a range of stem cell-derived exosome products.
With 7 types of immune cell products and 34 types of stem cell products in development, the company showcases its extensive research capabilities and visionary approach to advancing the field.
The company’s laboratory has earned the national ISO 9001 quality system certification, reflecting its dedication to maintaining the highest standards in quality management and operational excellence.
The company’s stem cell products are certified by the China Institute of Blood Transfusion, a testament to their unwavering commitment to quality and reliability. Furthermore, the quality evaluation process for exosome detection complies with the international external quality
assessment system certification, underscoring the company’s dedication to meeting and exceeding global quality standards.
At the forefront of the industry, the company combines cutting-edge research, innovative product development, and rigorous quality management to deliver excellence in every aspect of its
operations.
History
Founded in 2022, the company is strategically located in the Economic Development Zone of Chengdu’s Science and Technology Incubator Park. Starting with a 1,500-square-meter space, it has ambitious plans to expand to a 3,000-square-meter site, where it aims to build
cutting-edge R&D and office facilities. From its inception, the company has been deeply
committed to advancing research in stem cells and immune cells, exploring their potential in
fields like regenerative medicine and immunotherapy. By assembling a team of top-tier scientific talent and leveraging advanced research equipment, the company is determined to make
significant contributions to the biotech industry, both in China and globally.
The facility is equipped with state-of-the-art instruments, including flow cytometers, biological safety cabinets, electron microscopes, cell counters, CO₂ incubators, -80°C freezers, -196°C liquid nitrogen tanks, constant-temperature water baths, and high-speed and low-speed centrifuges, among others.
Our Team
The company currently employs 70 full-time and part-time staff members. This includes
● an expert group comprising 4 leading field experts,
● a research team consisting of 1 postdoctoral researcher, 2 PhDs, and 5 master's degree holders,
● a technology team of 11 members, and
● a technology transfer and service team with 14 members.
CELL’S EXOSOMES THE NEW WORLD MEDICINE
Introduction
Pioneering Stem Cell and Immune Cell Research
The company is a leading research-driven organization specializing in stem cell and immune cell research. It excels at turning scientific breakthroughs into practical solutions, and is also a dedicated producer of a range of stem cell-derived exosome products.
With 7 types of immune cell products and 34 types of stem cell products in development, the company showcases its extensive research capabilities and visionary approach to advancing the field.
The company’s laboratory has earned the national ISO 9001 quality system certification, reflecting its dedication to maintaining the highest standards in quality management and operational excellence.
The company’s stem cell products are certified by the China Institute of Blood Transfusion, a testament to their unwavering commitment to quality and reliability. Furthermore, the quality evaluation process for exosome detection complies with the international external quality
assessment system certification, underscoring the company’s dedication to meeting and exceeding global quality standards.
At the forefront of the industry, the company combines cutting-edge research, innovative product development, and rigorous quality management to deliver excellence in every aspect of its
operations.
History
Founded in 2022, the company is strategically located in the Economic Development Zone of Chengdu’s Science and Technology Incubator Park. Starting with a 1,500-square-meter space, it has ambitious plans to expand to a 3,000-square-meter site, where it aims to build
cutting-edge R&D and office facilities. From its inception, the company has been deeply
committed to advancing research in stem cells and immune cells, exploring their potential in
fields like regenerative medicine and immunotherapy. By assembling a team of top-tier scientific talent and leveraging advanced research equipment, the company is determined to make
significant contributions to the biotech industry, both in China and globally.
Our Team
The company currently employs 70 full-time and part-time staff members. This includes
● an expert group comprising 4 leading field experts,
● a research team consisting of 1 postdoctoral researcher, 2 PhDs, and 5 master's degree holders,
● a technology team of 11 members, and
● a technology transfer and service team with 14 members.